Passive transfer of arthritis by purified anticollagen immunoglobulin: Localization of 125I-labeled antibody

S. S. Kerwar; Samuel Gordon; Richard A. McReynolds; Arnold L. Oronsky

doi:10.1016/0090-1229(83)90033-8

Passive transfer of arthritis by purified anticollagen immunoglobulin: Localization of 125I-labeled antibody

S. S. Kerwar, Samuel Gordon, Richard A. McReynolds, Arnold L. Oronsky

Research output: Contribution to journal › Article

Abstract

Intravenous administration of purified ¹²⁵I-labeled anti-type II collagen immunoglobulin results in a polyarthritis in the recipient rats. Whole-animal radioautography indicates that the antibody is present in the various tissues that contain Type II collagen. However, the polyarthritic lesion is limited to the front and hind paws. These observations indicate that effector mechanisms subsequent to antibody binding are involved in the pathogenesis of Type II collagen-induced arthritis.

Original language	English (US)
Pages (from-to)	318-321
Number of pages	4
Journal	Clinical Immunology and Immunopathology
Volume	29
Issue number	2
DOIs	https://doi.org/10.1016/0090-1229(83)90033-8
Publication status	Published - 1983
Externally published	Yes

Fingerprint

ASJC Scopus subject areas

Immunology
Immunology and Allergy
Pathology and Forensic Medicine

Cite this

Kerwar, S. S., Gordon, S., McReynolds, R. A., & Oronsky, A. L. (1983). Passive transfer of arthritis by purified anticollagen immunoglobulin: Localization of 125I-labeled antibody. Clinical Immunology and Immunopathology, 29(2), 318-321. https://doi.org/10.1016/0090-1229(83)90033-8

@article{888aa65145a94d1ab93d1539bc7523e9,

title = "Passive transfer of arthritis by purified anticollagen immunoglobulin: Localization of 125I-labeled antibody",

abstract = "Intravenous administration of purified 125I-labeled anti-type II collagen immunoglobulin results in a polyarthritis in the recipient rats. Whole-animal radioautography indicates that the antibody is present in the various tissues that contain Type II collagen. However, the polyarthritic lesion is limited to the front and hind paws. These observations indicate that effector mechanisms subsequent to antibody binding are involved in the pathogenesis of Type II collagen-induced arthritis.",

author = "Kerwar, {S. S.} and Samuel Gordon and McReynolds, {Richard A.} and Oronsky, {Arnold L.}",

year = "1983",

doi = "10.1016/0090-1229(83)90033-8",

language = "English (US)",

volume = "29",

pages = "318--321",

journal = "Clinical Immunology",

issn = "1521-6616",

publisher = "Academic Press Inc.",

number = "2",

}

TY - JOUR

T1 - Passive transfer of arthritis by purified anticollagen immunoglobulin

T2 - Localization of 125I-labeled antibody

AU - Kerwar, S. S.

AU - Gordon, Samuel

AU - McReynolds, Richard A.

AU - Oronsky, Arnold L.

PY - 1983

Y1 - 1983

N2 - Intravenous administration of purified 125I-labeled anti-type II collagen immunoglobulin results in a polyarthritis in the recipient rats. Whole-animal radioautography indicates that the antibody is present in the various tissues that contain Type II collagen. However, the polyarthritic lesion is limited to the front and hind paws. These observations indicate that effector mechanisms subsequent to antibody binding are involved in the pathogenesis of Type II collagen-induced arthritis.

AB - Intravenous administration of purified 125I-labeled anti-type II collagen immunoglobulin results in a polyarthritis in the recipient rats. Whole-animal radioautography indicates that the antibody is present in the various tissues that contain Type II collagen. However, the polyarthritic lesion is limited to the front and hind paws. These observations indicate that effector mechanisms subsequent to antibody binding are involved in the pathogenesis of Type II collagen-induced arthritis.

UR - http://www.scopus.com/inward/record.url?scp=0020516049&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020516049&partnerID=8YFLogxK

U2 - 10.1016/0090-1229(83)90033-8

DO - 10.1016/0090-1229(83)90033-8

M3 - Article

C2 - 6627761

AN - SCOPUS:0020516049

VL - 29

SP - 318

EP - 321

JO - Clinical Immunology

JF - Clinical Immunology

SN - 1521-6616

IS - 2

ER -

Access to Document

10.1016/0090-1229(83)90033-8